SRDX | tickerfilter.com

Fundamental analysis

32%

Profitability 39%

Dept financing 33%

Liquidity 50%

Performance 20%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.40%

1 Month

0.25%

3 Months

3.15%

6 Months

-5.43%

1 Year

6.84%

2 Year

21.01%

Key data

Stock price

$39.60

P/E Ratio

-404.15

DAY RANGE

$39.52 - $39.94

EPS

-$0.10

52 WEEK RANGE

$25.87 - $42.43

52 WEEK CHANGE

$7.45

MARKET CAP

565.401 M

YIELD

N/A

SHARES OUTSTANDING

14.267 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/06/2024

BETA

0.58

PUBLIC FLOAT

AVERAGE 10 VOLUME

$167,322

AVERAGE 30 VOLUME

$167,075

Company detail

CEO: Gary R. Maharaj
Region: US
Website: surmodics.com
Employees: 450
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Surmodics, Inc. provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices. The IVD segment designs, develops, and manufactures component products and technologies for diagnostics. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

SRDX - SURMODICS INC